IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin by Dalessandri, T et al.
ARTICLE
Received 18 Jan 2016 | Accepted 26 May 2016 | Published 30 Jun 2016
IL-13 from intraepithelial lymphocytes regulates
tissue homeostasis and protects against
carcinogenesis in the skin
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The skin is under constant renewal and exposure to environmental challenges. How
homeostasis is maintained alongside protective mechanisms against damage is unclear.
Among the basal epithelial cells (ECs) is a population of resident intraepithelial lymphocytes
(IELs) that provide host-protective immune surveillance. Here we show that IELs
cross-communicate with ECs via the production of IL-13. Skin ECs are activated by IEL-derived
IL-13, enabling a canonical EC stress response. In the absence of IL-13, or canonical IEL, the
skin has decreased ability to repair its barrier and increased susceptibility to cutaneous
carcinogenesis. IL-13 controls the rate of EC movement through the epidermis, which might
explain the importance of IL-13 for epidermal integrity and its suppressive effect on skin
carcinogenesis. These ﬁndings show that IL-13 acts as a molecular bridge between IELs and
ECs, and reveal a critical host-defensive role for type-2 immunity in regulating EC tissue
homeostasis and carcinogenesis.
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I
mmune surveillance refers to the capacity of the immune
system to sense cellular dysregulation and respond to
restore homeostasis. This continued ‘quality control’
mechanism has most commonly been studied in relation to
cancer1–4. However, the concept of immune surveillance can
also be more broadly applied to non-malignant pathologies and
homeostatic tissue control5.
The epithelial barriers of our body surface tissues are
continually exposed to environmental challenges and must
respond appropriately to maintain tissue integrity. Epithelial
cells (ECs), which line body surface tissues, are dynamic and
versatile cells, and evidence indicates that they are important
drivers of immune surveillance6. In close association with ECs
are the specialized tissue-resident T cells known as intraepithelial
lymphocytes (IELs). IELs constitute a large, but somewhat
enigmatic, population of T lymphocytes. They carry
recombination activating gene (RAG)-dependent rearranged
T-cell receptors (TCRs), yet have limited TCR diversity and are
mainly major histocompatibility complex non-restricted cells.
They express innate receptors that enable reaction to stress
antigens with rapid ‘innate-like’ response kinetics7. The murine
skin contains a unique subset of gd TCRþ IELs, called dendritic
epidermal T cells, that exclusively carry a Vg5Vd1 TCR and
constitutively express stress-sensing receptors such as NKG2D.
NKG2D ligands are induced on stressed ECs, are expressed by
most epithelial tumours and the NKG2D pathway is strongly
associated with anti-tumour responses in both humans and mice8.
We have previously shown that skin IELs directly recognize and
respond to alterations in autologous stress antigens on local ECs
(keratinocytes (KCs)), including ligands for the NKG2D receptor9.
This rapid afferent sensing of stressed ECs probably has a crucial
role in the early detection of pre-malignant cells and has been
termed ‘lymphoid stress surveillance’ (LSS)10,11. Indeed, the
absence of canonical skin IELs confers a signiﬁcant increase in
the susceptibility to skin carcinogenesis9. Curiously, when
tumour-protective skin-resident IELs are activated by stressed
ECs in the LSS response, a dominant Th2-biased downstream
response is triggered with large amounts of interleukin (IL)-13 and
IgE being produced. This stress-induced type-2 immune response
is dependent on canonical IEL recognition of stressed ECs via the
NKG2D pathway12. Although Th2 immunity has traditionally
been thought to impair host tumour eradication, the surprising
association between a stress sensor such as NKG2D and induction
of type-2 immunity necessitates investigation into the role of early
type-2 immunity in cancer immune surveillance.
Stressed ECs promptly release many cytokines; among the
most robustly expressed are IL-25, IL-33 and thymic stromal
lymphopoietin (TSLP), all of which can drive type-2 immune
responses. This propensity of damaged epithelial tissues to induce
type-2 immunity may underlie the high frequency of allergic and
atopic disease at the skin and mucosal surfaces. However, despite
the intense interest in this area, the cellular and molecular basis of
how type-2 immunity is linked with EC dysregulation and barrier
disruption is not fully understood, nor is the functional role of
this type of immunity for EC homeostasis or immune surveillance
fully elucidated. The relationship between allergic disease and
cancer has been long-debated, but the biological nature of this
association is unclear. Overviews of the epidemiology literature
show both potent inverse and positive associations. This
divergence highlights the complexity of the underlying interac-
tions as well as reﬂects the heterogeneity of these diseases.
Intriguingly, inverse associations are more common for tissues
that interface with the external environment, such as the skin13,14.
Nonetheless, molecular mechanism(s) for how atopy may
translate into a distinct functional advantage against EC
carcinogenesis have not been described.
Here we investigate the importance of IEL–EC cross-talk and
type-2 immunity in skin homeostasis. We show that an important
part of LSS is rapid IL-13 production by IELs, and that this
provides a molecular bridge between the IELs and ECs.
IEL-derived IL-13 has prominent effects on skin ECs, enabling
a canonical EC response to stress with the release of TSLP and
IL-33, and accelerating the rate of EC movement through
the epidermis. Mice lacking IL-13, or canonical IEL, have
evidence of stress in the skin, with enhanced transepidermal
water loss (TEWL) and defects in the restoration of skin barrier
integrity after insult. In addition, mice lacking IL-13 are more
susceptible to cutaneous carcinogenesis. Hence, LSS-induced
type-2 immunity is part of an early ‘allergic’ host defence
mechanism regulating tissue homeostasis and protecting against
carcinogenesis.
Results
Skin IELs are potent producers of IL-13. The importance of
tissue-speciﬁc IELs for host protection is evident by the marked
increase in skin tumour susceptibility of mice lacking only
Vg5Vd1þ skin IELs9. The tumour protection conferred by gd
T cells has primarily been attributed to their cytotoxicity
and them being an early source of interferon-g (IFN-g)
(refs 15,16). However, we found that, when skin IELs were
activated in situ by a variety of environmental stressors, their
principal stress response was to produce type-2 cytokines,
primarily IL-13 (Fig. 1). In the resting skin, IELs are
morphologically very dendritic and use these dendrites to form
contact points with the ECs17 (Supplementary Fig. 1). Upon a
mild topical physical insult, or skin exposure to chemicals such as
12-O-tetradecanoylphorbol-13-acetate (TPA) or the carcinogen
7,12-dimethylbenz[a]anthracene (DMBA), IELs retracted their
dendrites and rounded up their cell bodies (Supplementary
Fig. 1), which parallels with IEL activation9. At the same time, IL-
13 was upregulated in the epidermal tissue. This was a conserved
response to stress and was seen both after exposure to physical
stressors, such as tape-stripping and shaving, or following
exposure to ultraviolet irradiation (UV) and chemicals such as
TPA or DMBA (Fig. 1a)—and even after transgenic upregulation
of NKG2D ligands on skin ECs12. The vast majority of freshly
isolated skin IELs stimulated ex vivo also produced potent
amounts of IL-13 protein within just a few hours, while they did
not produce IFN-g or IL-17 (Fig. 1b,c). Importantly, the IELs
were the only cells in the epidermis to produce IL-13 (Fig. 1d).
This IL-13 signature was unique to the Vg5Vd1þ skin IELs and
not a universal gd T-cell phenomenon, as systemic gd T cells
isolated from the skin draining lymph node or spleen did not
show this IL-13 bias (Fig. 1e; supplementary Fig. 2). Using IL-13-
egfp reporter mice, we found that Vg5Vd1þ epidermal IELs were
in fact positive for IL-13 already at steady state in the resting skin,
and that IL-13 expression was further upregulated following
in vivo topical exposure to TPA (Fig. 1f,g) and other
environmental challenges (Supplementary Fig. 3). In contrast,
Vg5 dermal gd T cells were negative for IL-13-egfp (Fig. 1f,g).
Hence, the epidermal IELs constitutively produce IL-13 at steady
state, show a distinctive and conserved IL-13 signature when
responding to environmental stress and are the only cells in the
epidermis to produce IL-13.
IEL-derived IL-13 activates skin ECs. IL-13 mediates its effects
by interacting with a complex receptor system comprised of
IL-4Ra and two IL-13-binding proteins, IL-13Ra1 and IL-13Ra2
(ref. 18). At steady state in the resting skin, all the basal keratin 5þ
KCs expressed the main IL-13Ra1 (Fig. 2a,b) and IL-4Ra1 and
IL-13Ra2 were also expressed by KCs (Supplementary Fig. 4).
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An important mechanism of modulating IL-13 responses
may be through the regulation of its receptors, and indeed
following topical skin abrasion (Supplementary Fig. 4A,B) or
exposure to DMBA (Supplementary Fig. 4C,D) both IL-4Ra1 and
IL-13Ra1 were further upregulated. The regulation of the IL-13
receptors appeared to be independent of IL-13, as a similar
upregulation on stressed KCs in vivo was seen in mice deﬁcient in
IL-13 (Supplementary Fig. 4C,D). The IL-13Rs on KCs were
active as addition of recombinant (r)IL-13 to primary KCs
in vitro induced further upregulation of IL-4Ra1 and particularly
of the ‘decoy’ receptor IL-13Ra2 (Supplementary Fig. 4E–G), as
well as production of TSLP, IL-1a and TNFa (Fig. 2c–e). In
parallel, IL-13 was essential for the canonical KC stress response
in vivo, as IL-13-deﬁcient mice exposed topically to the
carcinogen DMBA did not show the induction of TSLP, IL-33 or
caspase-3 seen in wild-type (WT) mice (Fig. 2f–h). To determine
whether IELs were the source of this IL-13, we exploited the fact
that skin IELs are radioresistant (Supplementary Fig. 5) and
generated bone marrow (BM) chimeras, in which IELs were the
only haematopoietic cells in the skin that could produce IL-13.
This was achieved by reconstituting irradiated WT mice with BM
from mice in which both IL-13 alleles had been replaced by egfp
(IL-13egfp/egfp-WT); for brevity, IL-13egfp/egfp mice are termed
IL-13 / henceforth. As controls, we generated chimeric mice
in which IELs were IL-13 deﬁcient, but other haematopoietic cells
were IL-13 sufﬁcient, by reconstituting irradiated IL-13 / mice
with WT BM (WT-IL-13 / ), as well as WT mice
reconstituted with WT BM (WT-WT) and IL-13 / mice
reconstituted with IL-13 / BM (IL-13 /-IL-13 / ). The
chimeric mice all had similar numbers of canonical IELs
and these were egfpþ in IL-13 /-IL-13 / and WT-
IL-13 / chimeras in which radioresistant host IELs were
attempting to produce IL-13, but not in chimeras containing WT
IELs (Supplementary Fig. 5D,E). Production of IL-13 was
upregulated further on stimulation of IELs with PMA and
ionomycin (Supplementary Fig. 5E). Conversely, egfpþ cells were
only found in other lymphoid tissues in chimeric mice
reconstituted with IL-13 / BM. Topical exposure of the
chimeric mice to DMBA showed that mice that lacked IL-13 in
the hematopoietic system, but had IL-13-sufﬁcient IELs, had a
normal KC response to stress, as shown by the induction of
TSLP and IL-33. In contrast, KCs from mice with IL-13-deﬁcient
IELs (but IL-13-sufﬁcient hematopoietic cells) did not respond
normally to DMBA-induced stress (Fig. 2i,j). We conclude that
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Figure 1 | Skin IELs are potent producers of IL-13. (a) Quantitative RT–PCR analysis of IL-13 mRNA in the epidermis isolated 4 h after the indicated topical
stress. Data are expressed as mean±1 s.e.m. relative to the control gene cyclophylin (n¼ 3–6 per condition). (b–d) Intracellular protein staining in Vg5þ
skin IELs following 4 h ex vivo stimulation with PMA/iono of (b–d) IL-13 and (c) IFN-g and IL-17. In d, CD45hi Vg5þ skin IELs (red) are shown with CD45mid
Langerinþ LCs (blue) and CD45 KCs (black). Representative FACS plots shown. (e) gd T cells isolated from the epidermis, LN or spleen compared for
intracellular IL-13 and INFg production following 4 h ex vivo stimulation with PMA/Iono (n¼ 3). (a–e) data from WT FVB mice. (f) Vg5þ and Vg5
TCRgdþ T cells isolated from naive skin of BALB/c mice (grey) and IL-13egfp reporter mice (black lines) and (g) 24 h after topical exposure to TPA.
(f) Shows histograms of the gfpþ gd Tcells and (g) the MFI of IL-13egfp before and after TPA challenge (n¼ 3 and 4). Statistical signiﬁcance of difference
was determined using Student’s t-test for unpaired data with ***Po0.001 and ****Po0.0001.
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IEL-derived IL-13 is central for a canonical KC stress response,
demonstrating the importance of an integrated local tissue
response to acute environmental challenges.
IEL and IL-13 sustain tissue health and restore integrity. To
determine the relevance of IELs and the role of IL-13 on the
health status of the epithelial tissue, we ﬁrst looked at the resting
steady-state skin. We found that the ECs appeared more stressed
and had signiﬁcant aberrant expression of the NKG2D ligand
Rae-1 when canonical IELs were absent. This was evident also in
total IL-13-deﬁcient mice and even in mice where IL-13 was
absent only in the IELs, while ECs in mice with IL-13-sufﬁcent
IELs had no or low expression of Rae-1 in spite of lacking IL-13
in the hematopoietic system (Fig. 3a,b). In addition,
quantiﬁcation of TEWL as a measure of skin integrity showed
that even the resting skin had a small but signiﬁcantly higher
degree of water loss in the absence of canonical IELs or IL-13
Keratin 5
CD
45
a b
Keratin 5
IL
-1
3R
α
1
0.00
0.01
0.02
0.03
0.04
0.05
R
el
at
iv
e 
ex
pr
es
sio
n
o
f T
SL
P
0.00
0.02
0.04
0.06
0.08
0.10
R
el
at
iv
e 
ex
pr
es
sio
n
o
f I
L-
1α
UT + rIL-13
0.0000
0.0005
0.0010
R
el
at
iv
e 
ex
pr
es
sio
n
o
f T
NF
-α
c d e
0 72
0.000
0.005
0.010
0.015
R
el
at
iv
e 
ex
pr
es
sio
n
o
f T
SL
P
Time (h)
WT
IL-13–/–
f
0 72
0.000
0.005
0.010
Time (h)
R
el
at
iv
e 
ex
pr
es
sio
n
o
f I
L-
33
g
0 72
0.000
0.001
0.002
0.003
0.004
R
el
at
iv
e 
ex
pr
es
sio
n
o
f c
as
p 
3
Time (h)
h
0.000
0.005
0.010
0.015
Time (h)
R
el
at
iv
e 
ex
pr
es
sio
n
o
f T
SL
P
WT->WT
IL-13–/–->IL-13–/–
IL-13–/–->WT
WT->IL-13–/–
0 24 72 0 24 72 0 24 72 0 24 72
0.00
0.02
0.04
Time (h)
R
el
at
iv
e 
ex
pr
es
sio
n
o
f I
L-
33
0 24 72 0 24 72 0 24 72 0 24 72
i j
**** *** *
* * *
****
****
****
****
**
***
UT + rIL-13UT + rIL-13
Figure 2 | IEL-derived IL-13 activates skin EC. (a,b) Epidermal cell suspensions from resting WT skin stained for CD45, keratin 5 and IL-13Ra1.
Representative examples shown. (c–e) Primary neonatal KCs cultured in vitro with/without 20 ngml 1 rIL-13 were assessed for expression of (c) TSLP,
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(Fig. 3c,d). Moreover, when the skin of mice lacking canonical
IELs or IL-13 was challenged by removing the stratum corneum
by tape-stripping, an increased degree of water loss was observed,
suggesting a worse barrier function and a poorer tolerance to
damage (Fig. 3e,f, inserts). More strikingly, mice deﬁcient in IELs
or IL-13 showed a signiﬁcantly impaired ability to repair the
integrity of the barrier and re-establishing tissue homeostasis after
the insult. The barrier was repaired much more slowly and even
5–6 days after insult, when WT skin was fully repaired, the
mutants still showed a signiﬁcant TEWL (Fig. 3e,f). Notably, this
barrier-repair defect could be rectiﬁed by adding topically rIL-13
after the insult—both in mice lacking canonical IELs and in mice
lacking IL-13 (Fig. 3g,h). Indeed, even topical application of IL-13
cytokine to WT mice after removal of the stratum corneum
sped-up the recovery of an intact barrier (Supplementary
Fig. 6A,B). However, for deeper skin insults beyond the
epithelium, IL-13 was redundant in the repair of full skin
thickness wounds (Supplementary Fig. 7), although closure of
full-thickness skin wounds are signiﬁcantly delayed in gd
T-cell-deﬁcient mice19,20. Thus, skin IELs and their IL-13
production are vital in maintaining a healthy epithelium and
play an important role in restoring epithelial tissue integrity
following insult.
IL-13 protects against cutaneous epithelial carcinogenesis. We
have shown that the same IEL that is host-protective against
inﬂammation-driven carcinogenesis is also a strong driver of
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type-2 immunity9,12 and local IL-13 responses (Fig. 1). Hence, we
wanted to examine the role of IL-13 in epithelial carcinogenesis.
We assessed skin tumour formation in IL-13-deﬁcient mice using
two different models of spontaneous epithelial carcinogenesis.
First, we evoked ‘DMBA complete’ carcinogenesis by exposing
the back skin once weekly to the carcinogen DMBA. This does
not cause inﬂammation in the tissue, but the ensuing
accumulation of mutations in the ECs causes the outgrowth of
tumours. Mice lacking IL-13 were signiﬁcantly more susceptible
to DMBA-induced carcinogenesis and developed both more and
bigger tumours than WT mice (Fig. 4a,b). Mice deﬁcient in
canonical IELs were also highly susceptible to DMBA complete
carcinogenesis, developing tumours earlier, as well as signiﬁcantly
more and bigger tumours than their WT counterparts (Fig. 4c,d).
Next, we examined the commonly used model of DMBA–TPA
carcinogenesis, where a single subcarcinogenic dose of DMBA,
which causes EC mutations primarily in hras (initiation), is
followed by repeated applications of the inﬂammatory reagent
TPA (promotion), which allows for the few mutated clones to
expand and form tumours. gd T-cell-deﬁcient and Vg5Vd1þ
IEL-deﬁcient mice are more susceptible to this form of two-stage
chemical cutaneous carcinogenesis9,15. Consistent with this,
mice lacking IL-13 were also more susceptible to this
inﬂammation-driven carcinogenesis and developed signiﬁcantly
more and bigger tumours than WT controls (Fig. 4e,f). This is
speciﬁc to IL-13 as mice lacking IL-4 were signiﬁcantly less
susceptible to tumour development following DMBA–TPA,
suggesting that IL-4 may drive inﬂammation in this model,
whereas IL-13 works differently (Fig. 4g,h). A constraint on this
interpretation is the caveat that the IL-13 and IL-4 mutant mice
used in this study were on a different background strain.
There are well-known differences in susceptibility to DMBA–
TPA carcinogenesis across different background strains21,
making direct comparison between mutants challenging. All
experiments on mutant strains were internally controlled with
the appropriate background strain. Furthermore, using BM
chimeric mice, we were additionally able to show that mice
lacking IL-13 only in the IELs (WT-IL-13 / ) were as
susceptible to DMBA carcinogenesis as mice completely lacking
IL-13 and both mutants developed more tumours than WT
(Fig. 4i). The increased susceptibility of IL-13 / mice to
DMBA carcinogenesis was not due to an increased absorption of
the carcinogen through the barrier-disrupted skin or an increased
metabolism of DMBA due to differences in LCs or other
skin DC populations (Supplementary Fig. 8), as the level of
double-stranded DNA breaks in ECs caused by the initial DMBA
exposure was similar between WT and IL-13 / mice
(Supplementary Fig. 9). The tumour-protective effect of IL-13
additionally appears to be restricted to carcinogenesis at the
epithelial skin barrier, as mice lacking IL-13 were not more
susceptible to subcutaneous tumour growth (Supplementary
Fig. 10). Together, this demonstrates that IL-13 is strongly
protective against cutaneous epithelial carcinogenesis.
IL-13 promotes EC maturation and transit through epidermis.
To explore how IL-13 promotes tissue integrity and protects
against carcinogenesis, we studied its effect on epidermal
structure and maintenance. The skin epithelium is under
constant renewal. KCs move from the basal proliferative layer up
through the spinal and granular layers undergoing differentiation
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Figure 4 | IELs and IL-13 protect against cutaneous epithelial
carcinogenesis. (a–d) The shaved backs of mice were treated once weekly
with 200nmol DMBA to evoke ‘complete DMBA’ carcinogenesis. Animals
were scored, tumours counted and measured once weekly. Data are
expressed as average number of tumours per (a) BALB/c WT and
IL-13 / mouse, and (c) FVB WT and Tcrd / mouse, and average
tumour size per (b) BALB/c WTand IL-13 / mouse, and (d) FVBWTand
Tcrd / mouse (n¼ 10–14 per group). (e–h) The shaved backs of mice
were treated with a single subcarcinogenic dose of DMBA followed by
twice weekly application of TPA to promote chronic skin inﬂammation and
outgrowth of tumours. Mice were scored weekly and the data expressed as
(e,g) average tumour number or (f,h) tumour size per (e,f) BALB/c WTor
IL-13 / mouse (n¼ 12 per group) or (g,h) FVB WT or IL-4 / mouse
(n¼ 10 per group). Statistical signiﬁcance between groups was assessed
over time using linear regression. (i) BALB/c WT/IL-13 / BM chimera
mice were generated as described and 8 weeks later the mice were
subjected to ‘DMBA complete’ carcinogenesis. Data show the average
number of tumours per mouse at the end of the experiment, week 17.
WT donor to IL-13 / host have IL-13-deﬁcient IELs (n¼8 per group).
Statistical signiﬁcance of difference between experimental groups was
determined using Student’s t-test for unpaired data with *Po0.05 and
**Po0.01. NS, not signiﬁcant.
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and maturation before entering terminal differentiation and
programmed cell death to form the corniﬁed stratum corneum.
To maintain tissue integrity and stability KCs express a multitude
of structural proteins and complexes of scaffolding and adhesive
proteins, which are tightly regulated during KC differentiation.
In line with the barrier-repair defect that we found in the absence
of IL-13 (Fig. 3), we also consistently found a reduced expression
of tight junction proteins and structural components of the upper
epidermis in IL-13-deﬁcient mice when challenged in vivo to
repair the barrier following tape-stripping (Fig. 5a–d). While
BALB/c WT mice upregulated the expression of claudin-1,
occludin and transglutaminase 1 at 24–48 h after the insult, in
accordance with morphological tissue repair, this response was
diminished in the absence of IL-13. FVB mice lacking epidermal
IELs also showed diminished expression of claudin-1 and trans-
glutaminase 1 after insult, but the kinetics of the response was
slightly different on the FVB strain background (Supplementary
Fig. 11). In addition, adding rIL-13 to primary KCs in vitro
strongly downregulated genes associated with basal KCs such as
K5 and K15 (Fig. 5e,f), suggesting that IL-13 promotes
upward-moving KC maturation. This was supported by
IL-13-induced expression of products associated with terminal
differentiation such as caspase-3 both in vivo and in vitro (Figs 2h
and 5g)22. To explore this further, we studied the rate of KC
transit through the epidermis in a bromodeoxyuridine (BrdU)
pulse-chase experiment. BrdUþ cells were counted in the basal
epidermal layer along the basement membrane and compared
with the number of BrdUþ cells in the granular layers; the role of
IL-13 in this KC turnover and migration was evaluated at steady
state and following topical exposure to TPA. In steady-state
resting tissue, there were only few proliferating cells, these were
nearly all in the basal layer—and there was no obvious difference
between WT and IL-13-deﬁcient mice (Fig. 5h). Following topical
TPA application, many more KCs were proliferating and
approximately half of these had moved into the granular layer
in WT. However, in mice lacking IL-13, although more cells were
proliferating than in the resting skin, these were nearly all in the
basal layer and only very few had moved into the granular
layers (Fig. 5i,k). This was particularly evident if the ratio of
granular to basal BrdUþ cells was compared (Fig. 5j), illustrating
that the KCs were migrating at a faster rate in IL-13-sufﬁcient
mice. As a result, the epidermis was also thinner in mice lacking
IL-13 (Fig. 5k), consistent with previous reports showing that
transgenic overexpression of IL-13 in basal KCs induces
thickening of the epidermal layer23. Overall, the thickening
of the total ear skin was reduced following topical TPA in
IL-13-deﬁcent mice (Fig. 5l). Together, this shows that the rate of
EC movement from the basal layer is under control of IL-13 and
hence IL-13 contributes to the upwards maturation of skin ECs
and epithelial renewal.
This effect on EC transit time may possibly contribute to
carcinogenesis susceptibility. In support of this, mice lacking
canonical epidermal IELs had a higher level of mutant hras (A-T
transversion within hras codon 61) in the epidermis following
DMBA exposure but before clinical signs of disease, suggesting that
the mutated cells accumulate in the tissue (Supplementary Fig. 12).
Discussion
Immune surveillance can function by many (non-exclusive)
mechanisms; it can recognize and remove damaged cells, remove
or neutralize potential harmful environmental substances,
facilitate re-establishment of homeostasis by tissue repair and
dampen detrimental inﬂammation. Tissue-resident immunocytes
are in a unique position to carry out a continued maintenance
function such as immune stress surveillance and tissue-resident
T cells can be direct afferent sensors of EC dysregulation9,12. This
study provides insight into one mechanism, whereby gd TCRþ
IELs contribute to immune surveillance through direct action on
neighbouring ECs, promoting tissue repair and protection against
tumour formation. A general picture of an important role for gd
T cells, which are highly tissue-tropic, in cancer immune
surveillance in both mouse and human is emerging. A recent
large meta-analysis, integrating tumour gene expression with
survival data, revealed the presence of intra-tumoral gd T cells as
the most signiﬁcant favourable prognostic population of all
leukocytes across human cancers24.
We show here that skin-resident gd TCRþ IELs are potent
producers of IL-13, following a variety of environmental stressors
and this greatly affects EC function with pleiotropic consequences
for tissue health. Human epidermal gd T cells have likewise been
shown to be high producers of type-2 cytokines—and particularly
IL-13 (ref. 25). While much has been published on the effects of
excessive expression of IL-4/IL-13 on the skin barrier in
inﬂammatory skin diseases such as atopic dermatitis (AD), the
potential role of constitutive expression of IL-13 has hitherto been
less well understood. Both IELs, resident in the epidermis, and
ILC2s, resident in the dermis, are constitutively positive for IL-13.
ILC2s are increasingly acknowledged to be regulating cutaneous
immune response26,27; however, they appear redundant in
supporting acute EC responses in the epidermis. ILCs are
ablated by radiation and re-populated by BM cells (data not
shown and refs 26,28), whereas IELs are radioresistant, so by
generating BM chimeras we could reveal the important role of
IEL-derived IL-13 for homeostatic responses in the epithelium.
Overall, our study demonstrates that constitutive presence of
IL-13 in the epidermis promotes barrier integrity and protects
against carcinogenesis.
The regulation and function of type-2 immunity remain
somewhat enigmatic. What is known so far of the physiological
role of type-2 responses is that their host-protection properties
converge in different forms of barrier defences29. Much of type-2
immunity appears dedicated to tissue repair and promoting
tolerance to damage. Our data on IL-13 in the epidermis ﬁts
with this idea and is consistent with the previous data from gd
T-cell-deﬁcient mice showing defects in the integrity of the
epidermal barrier as well as a predisposition to develop
spontaneous dermatitis30,31. A similar protective role for
IL-13Ra1 signalling in ECs during lung injury and homeostasis
has recently been reported32. This role for IL-13 in supporting
‘EC health’ contrasts with the prevailing paradigm in AD,
where the over-production of IL-13 is thought partly responsible
for the abnormal epithelial barrier phenotype33,34. Type-2
cytokines are clearly upregulated in the barrier-disrupted skin
in mice and in humans with AD35–37, but whether this is the
cause or effect of skin disease has long been debated. In AD, most
of the type-2 cytokines comes from the inﬂammatory inﬁltrate
and it may well be that the ‘over-production’ of IL-13 in this
setting is too much/at the wrong time/from the wrong cells and is
indeed detrimental for epidermal stability as studies from
in vitro grown KC suggest34,38. However, as shown here,
during acute insults, the homeostatic IL-13 response in vivo is
clearly important for pushing basal KCs upwards and thereby
aids the replenishing of the upper mature epidermis (Figs 5 and
3). This role for IL-13 as an ‘epithelial escalator’ has
previously been demonstrated in the gut epithelium, where it is
thought that this is why IL-13 is essential for gut parasite
expulsion39. Indeed, a recent study expands on this, and supports
our described role of IL-13 in controlling EC fate decisions, by
showing how IL-13 from intestinal ILCs regulate the cellular
composition of the gut epithelium by signalling to uncommitted
intestinal ECs40.
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In terms of early cancer immune surveillance, the role of type-2
immunity has been little explored; the focus having been ﬁrmly
on type-1 immunity and cytotoxic mechanisms, both of which
have strong experimental support for playing a role in extrinsic
tumour suppression. Nonetheless, the repair functions of type-2
immune surveillance are clearly important in protection against
carcinogenesis, as illustrated by the link between wounding and
tumour development41. Tumours can develop at the site of
chronic skin wounds42,43 and patients with epidermolysis bullosa,
who have chronic skin damage, are at increased risk of developing
squamous cell carcinoma44,45. A diminished capacity to repair a
damaged barrier can thus predispose to the development of
cancer. Our data support this link, as deﬁciency in IL-13 resulted
in both a barrier defect with reduced capacity to restore tissue
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integrity on insult and a signiﬁcantly higher susceptibility to
cutaneous carcinogenesis (Figs 3 and 4). A protective role for
IL-13 in inﬂammation-driven skin carcinogenesis has previously
been reported46 and ‘atopic’ mice have likewise been shown to be
protected36. Cipolat et al. showed that mice with a genetic barrier
defect had an exaggerated type-2 response, including IL-13 and
TSLP, and were protected against DMBA–TPA carcinogenesis.
The ‘atopic’ phenotype could be inhibited by blocking TSLP or
NKG2D36, suggesting that LSS responses are induced by
barrier disruption and protect against carcinogenesis also in
this model. A homeostatic IL-13 response thus ensures normal
tissue integrity (Fig. 3), but enhanced responses can induce
hyperplasia and thickening of the epidermis (Fig. 5), which may
primarily be driven by TSLP47. Acute hyperplasia results in
improved resistance to damage and damaging substances at the
body barrier and may therefore be another protective mechanism
against carcinogenesis. The data presented here, showing a
protective role for IL-13 in different models of epithelial
carcinogenesis, provides new perspective to further studies on
the links between atopy and cancer.
The association between defective tissue repair and cancer
development may not only pertain to the lack of repair per se but
also to the detrimental inﬂammation caused by chronic wounds.
There is a close link between chronic inﬂammation and cancer,
and once a malignant cell has escaped the early phase of immune
surveillance, inﬂammation can exert prominent pro-carcinogenic
effects48. An important component of early tumour surveillance
could hence be the release of anti-inﬂammatory products in the
tissue. IL-13 can have direct anti-inﬂammatory effects in
the epithelial tissue as shown in the intestinal epithelium49, but
recently a lot of focus has been on the more newly discovered EC
cytokines—IL-33, TSLP and IL-25. Skin ECs promptly produce
particularly IL-33 and TSLP upon stress, as when exposed to the
carcinogen DMBA. Interestingly, this canonical EC stress response
is under control of IEL-derived IL-13 (Fig. 2f–j). TSLP has been
implicated in the development and progression of allergic diseases,
in both human and mouse, in many recent studies and is thought
to be a central regulator of atopy in several epithelial tissues50.
TSLP is, however, also emerging as a potent tumour suppressor51.
In the skin, TSLP is strongly protective against carcinogenesis52,53
and this is thought to be due to EC-derived TSLP perturbing the
balance of inﬂammation in the tissue53. Clearly, not all type-2
immunity is anti-inﬂammatory. In this study, we show an
interesting divergent effect of the type-2 cytokines IL-4 and IL-
13 in inﬂammation-driven carcinogenesis. While IL-13 is
protective, IL-4 clearly promotes tumour growth in this model
(Fig. 4) and is mainly produced by the inﬂammatory inﬁltrate. It is
interesting that, although these cytokines share many regulatory
elements and have partially shared receptors, their expression
pattern is often different54 and they have previously been shown
to play distinct roles in asthma55. Indeed, the spatial and temporal
expression of these divergent cytokines may also be very
important in AD and further mechanistic studies are warranted
to understand the role of type-2 immunity in regulating skin
barrier function.
The fact that IELs and IL-13 protect against epithelial
carcinogenesis, in both mutation- and inﬂammation-driven
models, suggest that, in contrast to IL-4, this IEL–EC axis of
communication plays a central regulatory role in addition to
suppressing inﬂammation. This may be due to the role of IELs
and IL-13 in controlling the rate of EC movement through the
epidermis. IL-13 accelerates EC turnover and transit towards the
upper epidermis. An increased ‘transit time’ of skin ECs from the
basal proliferative layer to the outer cell layers have previously
been shown to be tumour suppressive in skin carcinogenesis56.
Similarly, mice lacking the major structural protein keratin 10 in
the upper epidermis have a strongly accelerated EC turnover and
are signiﬁcantly protected against skin carcinogenesis, suggesting
an increased elimination of initiated KCs57. Conversely, skin cells
resistant to terminal differentiation have since long been
associated with initiation of carcinogenesis58.
In summary, we demonstrate that IL-13 acts as a molecular
bridge between the skin IELs and ECs. This cross-communication
regulates EC function and promotes skin homeostasis in a manner
that protects against acute challenge and carcinogenesis. LSS is thus
part of an early ‘allergic’ type-2 host-defence mechanism aimed at
protecting body surface tissues. A similar role for IL-13 in EC
protection and homeostasis in the gut39,40 and lung32,59,60 raises the
possibility that this may represent a conserved response against
noxious environmental substances and damage to ECs—with
potential important implications for atopy and cancer.
Methods
Mice. IL-13-egfp reporter mice were generated as described61 and bred to
homozygosity for use as IL-13 / . IL-13-egfp mice were on BALB/c strain
background. Tcrd / mice62 and IL-4 / were backcrossed onto FVB/N
background410 generations. BALB/c and FVB/N WT mice were purchased from
Charles River and used as controls. For experiments requiring neonatal KCs,
neonatal mice were bred in-house. Mice were bred and maintained in individually
ventilated cages under speciﬁc pathogen-free conditions; with food and water
provided ad libitum. Age-matched, female mice were used for all experiments at
Z7 weeks of age. All studies were approved by Imperial College AWERB (Animal
Welfare and Ethical Review Body) and the UK Home Ofﬁce for Laboratory Animal
Care regulations. Experiments involving cancer studies strictly adhered to the
guidelines set out by the National Cancer Research Institute (NCRI) and Workman
et al.63 in ‘Guidelines for the Welfare and Use of Animals in Cancer Research’, and
all studies using animals were conducted following the Animal Research: Reporting
In Vivo Experiments (ARRIVE) guidelines64.
BM chimeras. Mice were sub-lethally irradiated (750 rad) and immediately
reconstituted with 5 106 donor BM cells intravenous. Mice were left for 8 weeks,
to fully reconstitute the hematopoietic system, and thereafter the reconstitution was
Figure 5 | IL-13 promotes epithelial maturation and transit through the epidermis. Expression analysis of (a) claudin-1, (b) occludin, (c)
transglutaminase 1 and (d) corneodesmosin in isolated epidermis from BALB/c WTmice (black bars) and IL-13 / mice (orange bars) at indicated time
points after skin abrasion by tape-stripping (nn¼ 3 per time point). (e–g) Primary neonatal KCs grown in vitro were stimulated with 20 ngml 1 rIL-13 or left
untreated (UT) and analysed for expression of the basal KC genes (e) Keratin 5 and (f) Keratin 15 as well as (g) caspase-3, which is associated with
terminal KC differentiation (n¼6). Data in (a–g) were done by qRT–PCR and are expressed as mean±1 s.e.m. relative to the control gene cyclophylin.
(h–k) BALB/c WT (black bars) and IL-13 / (orange bars) were treated topically with 10 nmol TPA on the dorsal ear skin or left untreated (n¼ 3 per
group). After 21 h, they were injected with 200 ml BrdU solution and 3 h later ear skin was ﬁxed in formalin, embedded in parafﬁn and BrdU staining
performed on 5 mm sections. BrdUþ events were counted along the entire length of untreated and treated epidermis. Epidermal BrdUþ cells on the basal
membrane were deﬁned as ‘basal’; BrdUþ epidermal cells not on the basal membrane were deﬁned as ‘granular’. Three 1-cm sections were counted per
mouse. (h) Number of BrdUþ cells in the basal and granular epidermis at steady state without treatment and (I) 24 h after topical exposure to TPA. (j) The
ratio of BrdUþ epidermal cells in the granular layer compared with the basal layer in BALB/c WTand IL-13 / mice. (k) Representative images of ear skin
24 h after exposure to TPA. Scale bar, 50mm (l) Ear thickness was measured with calipers at 24 h and 72 h after a single skin exposure to 10 nmol TPA on
the ear (n¼6 per group). Data are represented as mean±1 s.e.m. Statistical signiﬁcance of difference between experimental groups was determined using
Student’s t-test for unpaired data with *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001.
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examined by ﬂow cytometry (Supplementary Fig. 2). Chimeric mice were used for
experiments at Z8 weeks after BM reconstitution.
Tissue processing. Ears were collected and split into dorsal and ventral sides.
For isolation of intact epidermal sheets, the skin was ﬂoated dermal side-down in
0.5M NH4SCN for 40min, 37 C, 5% v/v CO2. Epidermal sheets were gently lifted
away from the dermis and washed in PBS. The ﬁxed epidermal sheets were then
processed either for RNA extraction or for microscopy. Reagents and staining
method for epidermal sheets can be found in the Supplementary Information.
For isolation of epidermal single cell suspensions, the skin was ﬂoated dermal
side-down in ﬁlter-sterilized, TrypLE Express (Life) solution for 2 h at 37 C,
5% v/v CO2. Following digestion, epidermis was separated from the dermis and
further digested in TrypLE Express solution supplemented with 200 mgml 1
DNAse I (Roche) and 1 DNAse buffer (1.21 g l 1 Tris Base, 0.5 g l 1 MgCl2 and
0.073 g l 1 CaCl2) on a rotator for 30min at 37 C. Cell suspensions were ﬁltered
and washed in PBS before ﬂow cytometry staining.
Flow cytometry staining. Cell suspensions were stained with a ﬁxable, live/dead
discrimination dye (Life) and subsequently blocked for non-speciﬁc binding using
antibody against FcgR (2.4G2) and 2% normal rat serum (Sigma). For staining of
cell surface markers, cell suspensions were stained with ﬂuorochrome-conjugated
antibodies and appropriate isotype controls for 40min and subsequently washed.
For intracellular cytokine staining cells were incubated for 4 h with brefeldin A at
10mgml 1, with or without PMA and ionomycin (6.25 ngml 1 and 3.5 mgml 1,
respectively). Following stimulation, cells were washed in PBS, resuspended and
ﬁxed/permed with Fixation and Permeabilization Buffer Set (Affymetrix, CA, USA)
before antibody labelling. For intranuclear gH2AX staining, cells were ﬁxed/
permed in ice-cold 70% ethanol at  20 C for 2 h, then blocked with 2% normal
mouse serum, Fc-block and 2% fetal calf serum for 15min, followed by 45min
staining for gH2AX at room temperature. Stained cells were analysed immediately
using a BD FACSVerse (BD Biosciences, NJ, USA) machine. Data analysis was
performed using FlowJo 10 for Mac (TreeStar, OR, USA). Antibodies were sourced
from eBioscience unless otherwise stated. The following antibodies were used:
CD45 (30-F11), Cytokeratin 5 (D516B4; Millipore), IFN-g (XMG1.2), IL-13
(eBio13A), IL-13 Ra1 / CD213a1 (13MOKA), TCR Vg5 (536; BioLegend), gH2AX
(JBW301; Millipore), CD64 (X54-5/7.1; BioLegend), CD11c (HL3), CD11b
(M1/70), CD207 (4C7; BioLegend), CD103 (2E7) and XCR1 (ZET; BioLegend).
Epidermal sheet immunoﬂuorescence. Epidermal sheets were ﬁxed in ice-cold
acetone at  20 C for 15min, then rehydrated in PBS and blocked with 2% bovine
serum albumin. Sheets were then stained with a ﬂuorescein isothiocyanate-
conjugated anti-Vg5 or anti-Langerin antibody and subsequently washed
thoroughly in PBS. Sheets were carefully mounted onto slides using anti-fade
mounting medium (Dako) and visualised on a Leica SP5 (Leica) confocal
microscope.
Immunohistochemistry. A 1 1-cm skin cut from the centre of the ears were
ﬁxed in formalin, embedded in parafﬁn and 5-mm sections cut. Slides were de-
waxed, antigen retrieval was performed with pH 6.0 sodium citrate treatment at
95 C for 15min, endogenous tissue peroxidase activity was blocked with H2O2
treatment, and non-speciﬁc binding was blocked with normal serum and ﬁsh skin
gelatin (Sigma). Non-speciﬁc avidin and biotin-binding sites were blocked with an
Avidin/Biotin blocking kit (VECTASTAIN). For BrdU detection, slides were
stained with anti-BrdU antibody (clone BU1/75; Abcam) in conjunction with a
three-layer immunohistochemistry kit (VECTASTAIN Elite ABC kit; Vectastain)
as per the manufacturer’s instructions. Staining was visualised with DAB substrate
and brown chromogen precipitation. Slides were counter stained in Harris’
haematoxylin acid solution, dehydrated and mounted with Pertex mouting.
Visual inspection of tissue and counting of BrdUþ cells were performed while
blinded to the experimental groups.
qRT–PCR and primer sequences. RNA was extracted from ammonium-ﬁxed
epidermis with an RNEasy Mini kit (Qiagen). RNA was dissolved in nuclease-free
water, and yield and purity were determined. Complementary DNA (cDNA) was
synthesised from RNA with a iScript cDNA synthesis kit (Bio-Rad) as per the
manufacturer’s instructions. cDNA was diluted in nuclease-free double-deionized
water for qRT–PCR. All primers were single-stranded DNA oligonucleotides
(Sigma) that were intron-spanning as veriﬁed by NCBI Primer-Blast tool.
Real-time PCR product was detected with SYBR Green (Life) measured
continuously with a ViiA 7 Real-Time PCR system (Applied Biosystems, CA,
USA). Ct values for genes of interest were normalised against Ct values of the
housekeeping gene Cyclophilin (Cyc) using the 2DCt method.
The following primers were used. F denotes forward primer (50–30) and R
denotes reverse primer (30–50). Il13 (F: 50-GCTTATTGAGGAGCTGAGCAAC
A-30 , R: 50-GCCAGGTCCACACTCCATA-30); Il4ra1 (F: 50-CCAATCAGACAG
ATACCAGATG-30 , R: 50-CCAGGTCAGCAGCCATTC-30); Il13ra1 (F: 50-AGAG
GTTGAAGAGGACAAATGCC-30 , R: 50-GCGACAAAGACTGGAATGGTGA
G-30); Il13ra2 (F: 50-CCGAAATGTTGATAGCGACAGC-30 , R: 50-CCAAGCCCT
CATACCAGAAAAAC-30); Tslp (F: 50-TCGAGGACTGTGAGAGCAAG-30 , R:
50-TGTTTTGTCGGGGAGTGAA-30); Il1a (F: 50-TTGGTTAAATGACCTGCAA
CA-30, R: 50-GAGCGCTCACGAACAGTTG-30); Tnfa (F: 50-ACTGGAGTTGTA
CGGCAGTG-30 , R: 50-GGCTGATCCCGTTGATTTCC-30); Casp3 (F: 50-GAGCT
TGGAACGGTACGCTA-30 , R: 50-50-GCGAGATGACATTCCAGTGC-30); Il33
(F: 50-CACATTGAGCATCCAAGGAA-30 , R: 50-AACAGATTGGTCATTGTA
TGTACTCAG-30); Rae1 (F: 50-TGGACACTCACAAGACCAATG-30 , R: 50-CCC
AGGTGGCACTAGGAGT-30); Claudin1 (F: 50-50-GCCATCTACGAGGGA
CTGTG-30 , R: 50-50-CACTAATGTCGCCAGACCTGAA-30); Occludin (F: 50-
TTGAACTGTGGATTGGCAGC-30 , R: 50-CAAGATAAGCGAACCTTGGCG-30);
Tgm1 (F: 50-CCTTGAGCTCCTCATTGGAA-30, R: 50-CCCTTACCCACTGGGA
TGAT-30); Cdsn (F: 50-AATGTCCAGCCCGGCATAAA-30 , R: 50-CAAGATTCC
TGGCAGAATAAGACC-30); K5 (F: 50-CATGTCTCGCCAGTCCAGTG-30 , R:
50-GGAACCGCACCTTGTCGATG-30); K15 (F: 50-50-GGAAGAGATCCGGG
ACAAA-30, R: 50-TGTCAATCTCCAGGACAACG-30); and Cyc (F: 50-CAAAT
GCTGGACCAAACACAA-30, R: 50-CCATCCAGCCATTCAGTCTTG-30).
DMBA-induced transversion mutation in hras (codon 61, CAA-CTA) was
quantiﬁed with a forward primer, mutant-speciﬁc reverse primer and a custom
generated TaqMan 60-FAM-conjugated probe for visualizing product: hras
C61CAA-CTA (F: 50-CTAAGCCTGTTGTTTTGCAGGAC-30 , R: 50-CATGGCA
CTATACTCTTCTA-30 ; Probe: 50-6FAM-CGGAAACAGGTGGTCAT-MGB-30).
Primary neonatal KC cultures. Body wall skin from neonatal mice was incubated
overnight at 4 C in 5Uml 1 Dispase (BD) solution supplemented with 1
antibiotic and antimycotic solution (Sigma). The epidermis was isolated and
further digested in TrypLE Express solution supplemented with 200 mgml 1
DNAse I and DNAse buffer. Cell suspensions were ﬁltered, resuspended in deﬁned
KC serum-free medium with supplements (Life)þ 1 antibiotic–antimycotic
solution. KCs were seeded at an appropriate cell density onto tissue culture vessels
coated with rat-tail-derived-collagen I (Sigma). Culture vessels were washed with
PBS 24 h following seeding to remove unattached cells, and provided with fresh
medium±20 ngml 1 recombinant IL-13 (R&D). For extraction of KCs, cell
culture vessels were treated with trypsin and KC RNA was subsequently extracted
using the RNEasy Mini kit (Qiagen).
Tape-stripping and TEWL. The stratum corneum was removed from the ear skin
by application and removal of cellophane tape (Scotch) six times per ear. For
measurement of TEWL, a tewameter probe (Tewameter TM300; Ck Electronic,
Germany) was placed directly onto the ear skin of anaesthetized mice in a
temperature- and humidity-controlled facility. Probe readings were analysed and
water evaporation rate was reported using the MPA software (MPA software; Ck
Electronic, Germany) as g hm 2 (where g¼water loss in grams, h¼ time in hours,
m2¼metres squared). For some experiments, mice were treated topically on the
ear skin with 50 ng rIL-13 (R&D), or vehicle control, immediately following tape-
stripping, and again 24 h later.
Chemical cutaneous carcinogenesis. The dorsal back area was shaved with a
surgical blade and mice rested for 1 week. Applications of chemicals and tumour
monitoring were performed as previously described15, 65. Chemicals, in a 100 ml
volume, were carefully and slowly applied by pipette to the entire shaved skin area.
For ‘DMBA complete’ carcinogenesis, mice were treated once weekly with
200 nmol DMBA. For two-stage ‘DMBAþTPA’ carcinogenesis, mice were
initiated with 200 nmol DMBA followed by twice weekly application of 10 nmol
(FVB background) or 20 nmol (BALB/c background) TPA. A slightly different
dosage between the background strains was chosen due to the well-known
difference in susceptibility to chemical skin carcinogenesis across strains21. Despite
this, the FVB background remained far more susceptible and developed a higher
tumour load. All experiments on mutant mice were controlled with the appropriate
background strain. Hair regrowth during experiments was gently removed by
clipping with trimmers. Mice were monitored daily and cutaneous tumours were
counted and measured with a caliper once weekly. Back skin and tumours were
evaluated by visual inspection by an observer blinded to the experimental groups.
Full skin thickness wounding. Mice were anaesthetized with inhalation isoﬂurane
and transferred onto a heat block with an anaesthetic nose-cone to maintain
anaesthesia throughout the procedure. Buprenorphine local analgesic (Vetergesic)
was administered subcutaneously around the area to be wounded. A single,
full-thickness 5-mm wound was made at the midline of the lower back using a
disposable sterile punch biopsy tool. Sterile paper bedding and wet food were
provided for 7 days following wounding. Wound size was measured daily with
calipers for the ﬁrst 2 days, and then once every 2 days until complete wound
closure. The wound sagittal (x) and transverse (y) plane were measured and
these were applied to the ellipse area formula to calculate wound area:
(area¼ p (radius x)(radius y)).
Subcutaneous tumour inoculation. The right ﬂank of mice was shaved and
1 104 CT26 cells injected subcutaneously into the ﬂank in 100 ml sterile PBS. The
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mice were inspected daily, the ﬂank was palpated and the tumour mass was
measured with calipers.
Statistical evaluation. The statistical signiﬁcance of difference between experi-
mental groups was determined using two-tailed Student’s t-test for unpaired data
or linear regression, where appropriate, with results deemed signiﬁcant at Po0.05.
Stars of signiﬁcance correlate to: *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001.
No mice were excluded from analysis. Statistics was performed with GraphPad
Prism 6.00 for Mac (GraphPad; La Jolla, CA, USA).
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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